New TB vaccine candidate enters human testing
⭐️ VACCINE ⭐️
Not yet recruiting
This study tests an experimental tuberculosis vaccine called Lipovaxin in healthy adults aged 18 to 40 in Indonesia. The vaccine is given as two shots, 28 days apart, and compared to a placebo. The main goals are to check if the vaccine is safe and whether it triggers an immune r…
Phase: PHASE1 • Sponsor: PT Bio Farma • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:00 UTC